In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.
Updates to the Australian Asthma Handbook will help health professionals advise patients with asthma during the COVID-19 vaccine rollout.
Australian researchers have found that the 2019–2020 bushfire season racked up smoke-related health costs of around $1.95 billion.
University of Leeds researchers have identified a pattern of long-term symptoms experienced by people hospitalised with COVID-19.
Dr Harrison Steel has been directly involved in two significant projects that have impacted the COVID-19 health crisis.
The National Asthma Council Australia has released a preview of the updated Australian Asthma Handbook V2.1.
The antiviral drug is the first medication to be recommended as a considered treatment for hospitalised patients with the condition.
A new self-administered treatment for severe eosinophilic asthma will be reimbursed by the Pharmaceutical Benefits Scheme from 1 June 2020.
A UK study has revealed that age, male sex, obesity and underlying illness emerge as risk factors for severe COVID-19 or death.
New insights into the molecular mechanisms driving mucus viscosity could help improve airway-clearing treatment options for patients with respiratory conditions.
Doctors are giving advice to the 2.7 million Australians with asthma about how the novel coronavirus affects them.
E-cigarettes containing nicotine are illegal in Australia. Some health experts believe they shouldn't be...
Are smokers more likely to contract COVID-19 than non-smokers? Are they likely to have worse outcomes? Two academics from UNSW Sydney discuss how coronavirus affects smokers.
The National COVID-19 Clinical Evidence Taskforce is developing 'living guidelines' to provide updated, evidence-based guidance to clinicians caring for COVID-19 patients.
The university has been asked to develop a vaccine for the coronavirus that could be available worldwide in as little as six months.